DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178,850,052 | -20.0% | 720,879 | -18.8% | 0.51% | +7.6% |
| Q1 2023 | $223,692,809 | -8.0% | 887,529 | -3.1% | 0.48% | -12.5% |
| Q4 2022 | $243,070,309 | +5.2% | 915,795 | +2.4% | 0.54% | -10.1% |
| Q3 2022 | $230,977,000 | +8.8% | 894,254 | +6.8% | 0.60% | +11.2% |
| Q2 2022 | $212,236,000 | -6.7% | 837,158 | +7.9% | 0.54% | +10.1% |
| Q1 2022 | $227,598,000 | -8.6% | 775,912 | +2.6% | 0.49% | -7.9% |
| Q4 2021 | $248,879,000 | +15.3% | 756,449 | +6.7% | 0.54% | +1.3% |
| Q3 2021 | $215,844,000 | +13.1% | 708,987 | -0.3% | 0.53% | +6.9% |
| Q2 2021 | $190,856,000 | +21.9% | 711,192 | +2.2% | 0.49% | -2.6% |
| Q1 2021 | $156,614,000 | -4.8% | 695,816 | -6.1% | 0.51% | -4.9% |
| Q4 2020 | $164,573,000 | +7.6% | 740,851 | +4.3% | 0.53% | -10.7% |
| Q3 2020 | $152,996,000 | +25.8% | 710,520 | +3.3% | 0.60% | +7.6% |
| Q2 2020 | $121,646,000 | +29.4% | 687,928 | +1.3% | 0.56% | +4.3% |
| Q1 2020 | $93,987,000 | -11.3% | 679,047 | -1.6% | 0.53% | +10.6% |
| Q4 2019 | $105,960,000 | +9.5% | 690,383 | +3.0% | 0.48% | -4.6% |
| Q3 2019 | $96,771,000 | +8.5% | 670,021 | +7.4% | 0.50% | +3.1% |
| Q2 2019 | $89,180,000 | +5.5% | 623,987 | -2.5% | 0.49% | +10.9% |
| Q1 2019 | $84,491,000 | +32.0% | 639,984 | +3.1% | 0.44% | +13.4% |
| Q4 2018 | $64,032,000 | +0.5% | 620,942 | +5.9% | 0.39% | +25.1% |
| Q3 2018 | $63,710,000 | +12.3% | 586,326 | +1.9% | 0.31% | -2.2% |
| Q2 2018 | $56,753,000 | +3.3% | 575,134 | +2.5% | 0.32% | -14.5% |
| Q1 2018 | $54,946,000 | +8.9% | 561,191 | +3.2% | 0.37% | +12.0% |
| Q4 2017 | $50,474,000 | +9.2% | 543,783 | +0.9% | 0.33% | -0.3% |
| Q3 2017 | $46,224,000 | +2.4% | 538,879 | +0.8% | 0.33% | -2.9% |
| Q2 2017 | $45,128,000 | +2.2% | 534,750 | +3.6% | 0.34% | +0.3% |
| Q1 2017 | $44,151,000 | +13.9% | 516,209 | +3.7% | 0.34% | +1.5% |
| Q4 2016 | $38,752,000 | +8.0% | 497,844 | +8.8% | 0.34% | +0.9% |
| Q3 2016 | $35,879,000 | -18.1% | 457,701 | +5.5% | 0.33% | -21.4% |
| Q2 2016 | $43,817,000 | +19.0% | 433,840 | +11.8% | 0.42% | +20.7% |
| Q1 2016 | $36,818,000 | +123.0% | 388,144 | +118.4% | 0.35% | +108.3% |
| Q4 2015 | $16,510,000 | +19.2% | 177,755 | +9.4% | 0.17% | -2.9% |
| Q3 2015 | $13,849,000 | +18.2% | 162,536 | +18.8% | 0.17% | +29.9% |
| Q2 2015 | $11,714,000 | +1.1% | 136,864 | +0.3% | 0.13% | +1.5% |
| Q1 2015 | $11,583,000 | +0.8% | 136,438 | +1.8% | 0.13% | -3.6% |
| Q4 2014 | $11,488,000 | +12.3% | 134,024 | -0.5% | 0.14% | +3.8% |
| Q3 2014 | $10,234,000 | -5.2% | 134,690 | -1.8% | 0.13% | -27.5% |
| Q2 2014 | $10,794,000 | +8.1% | 137,103 | +3.0% | 0.18% | 0.0% |
| Q1 2014 | $9,986,000 | +29.6% | 133,149 | +33.4% | 0.18% | +17.4% |
| Q4 2013 | $7,705,000 | +26.1% | 99,810 | +13.3% | 0.16% | +11.5% |
| Q3 2013 | $6,109,000 | +25.3% | 88,119 | +14.4% | 0.14% | +15.8% |
| Q2 2013 | $4,877,000 | – | 77,054 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |